Navigation Links
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol
Date:11/21/2007

rmulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become a fully integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit http://www.labopharm.com.

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein and depend on a number of factors, including the uncertainties related to the regulatory process for drug approval and the commercialization of the Company's products, if they are approved. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.


'/>"/>
SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. Labopharm Reports Results for Third Quarter Fiscal 2007
8. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
9. DaVita Receives Civil Complaint
10. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...f-assurance, research finds , , SUNDAY, ...en right when she told you to sit up straight: New...u feel more confident about your thoughts. , "...ves a good impression to other people," Richard Pe...ssor at Ohio State University, said in a universit...
(Date:11/8/2009)...e/ -- Speaker Nancy Pelosi and Democratic leaders ...e of H.R. 3962, the Affordable Health Care for Ame.... Below are the Speaker,s opening remarks: ,,... from the President of the United States, Barack O... American people. I thank the President for his tr...
(Date:11/8/2009)...pharmaceuticals to be available at the Company&rsq... Toronto, ON (PRWEB) November 8, 2009... Biopharma Inc. today announced that the Company h...ical grade freeze dryer and expects to make commer...e for contract manufacturing of biopharmaceuticals...
(Date:11/8/2009)...s won," said Dr. Charmaine Yoest. ,, WASHINGTO...240-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlkem...mandates and funding in HR 3962 passed on the Hous...esident and CEO Dr. Charmaine Yoest said, "The pas...fe Americans across this country who have flooded ...
(Date:11/8/2009)... Secure the Stability of Medicare ,, HOUSTON, ...utable to: J. James Rohack, M.D., President, Ameri....newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...reform bill, which will help improve the health sy...ft passage of H.R. 3961 to secure the stability of...
Breaking Medicine News(10 mins):Health News:Good Posture May Inspire Confidence 2Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
... Dundee United’s Chairman, Eddie Thompson, who was... now undergoing more advanced treatment// for the ... released by the Tannadice club officials on his b...nt began at Ninewells Hospital last week following...
... The Ministry of Health has brought out some alarm...mong Ontarians, which seems to be on the rise//. ...fficer, said, "The epidemic is continuing. The num...ortality rates have been reduced through the intro...
... The Canada Post Corporation, comprised of Canada'...he nation's sixth largest workforce// , the majori...on. Being a postal worker entails not only the typ...etal complaints rose from 53 percent in 2001 to 59...
... A new study finds a sharp increase in the number ... could have a worrisome implication for the nation...Harvard Medical School, who had published their fi...ts now are 59% more likely to be overweight than w...
... A new study has reported that there were many tee...y use a condom//. The study had shown that s...put the condom on too late or take it off too earl...nsmitted infections (STI). The study that ha...
... Julie Brown, from Livingston has accused the NHS ...hat she was still pregnant after undergoing treatm... town's St John's hospital had told her that the f...gnant. "A scan on Monday showed my baby was still ...
Other Medicine News:Health News:Naturopathic Care and Low Back Pain 2Health News:Naturopathic Care and Low Back Pain 3Health News:Study finds Babies In America Getting Fatter 2Health News:Teens In UK Do Not Know How To Use A Condom 2
(Date:11/7/2009)..., MIAMI BEACH, Fla., Nov. 7 Patie...trate is an effective therapy in treating acute sw...e and serious genetic disorder, according to data ...lergy, Asthma & Immunology (ACAAI) Annual Meet...of patients conducted in parallel with the ongoing...
(Date:11/6/2009)..., ,, FORT WASHINGTON, Pa., Nov. 6 /PRNewsw...g Administration (FDA), McNeil Consumer Healthcare...luntary recall of a limited number of product lots...bottles, with the distinctive red EZ-OPEN CAP. McN...uncharacteristic smell or taste associated with th...
(Date:11/6/2009)..., WESTBURY, N.Y., Nov. 6 Reposses...achine tools in the third quarter of 2009 declined...ng to Nassau Asset Management,s NasTrac Quarterly ...,s activity reports for both repossessions and ord...essions for both construction and printing equipme...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 1Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 2American Society for Microbiology honors Jo Handelsman 8703 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2
...pplication of key product in,AM-Pharma,s pipeline ...ma B.V., the,biopharmaceutical company developing ...atory diseases, today announced positive,results i...involved,were a subgroup of a Phase IIa trial with...eatinine clearance, a marker for renal function,i...
...07-- The cause of one notorious,childhood disease,...reat of another childhood disease, neuroblastoma. ...ers from Stony Brook University,report that an att...s effective in obliterating neuroblastoma tumors i...cinated against the virus. , By its nature, poliov...
Other Medicine Technology:AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 2AM-Pharma Announces Positive Results of a Phase IIa Clinical Trial,with Alkaline Phosphatase in Acute Renal Failure 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4
...medium designed for the direct detection and/or co...ted for the suppression of gram-negative organisms...eus hydrolyzes the chromogenic substrate resulting...n from other gram-positive organisms. A cephalospo...
Autoclavable Light Guides & Adapters
...h a 180 watt Xenon short arc lamp. Designed to pro... transfer from the lamp to the light guide, this l...alent to higher watt bulbs. A new IR filtering sys...mount of heat generated from the light source and ...
... your video equipment has led Linvatec to develop ...odate all of your multi-specialty video requiremen...ers in both traditional eyecup and proprietary fog...oom "C mount eyecup and both "C and "V mount eyecu...
Medicine Products: